Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) in patients 8 years of age or ...

Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...

Antibodies play a major role in neutralizing pathogens and preventing illness following infection of the host. In the current pandemic of the coronavirus disease 2019 (COVID-19), the levels of ...

The body has an intricate system to defend against infections where each type of immune cell plays a distinct role. Now, a study led by researchers from the Penn State College of Medicine has ...

Teplizumab has shown significant preservation of C-peptide levels in newly diagnosed type 1 diabetes (T1D) patients, indicating the potential for modifying disease progression. Combining teplizumab ...

HERSHEY, Pa. — The body has an intricate system to defend against infections where each type of immune cell plays a distinct role. Now, a study led by researchers from the Penn State College of ...

A study led by investigators from the Ragon Institute of MGH, MIT and Harvard finds evidence that antibody protection may help control infection with the bacteria that causes tuberculosis (TB). In ...

Antibodies perform like guided missiles, inspiring therapeutic developers to produce their own antibody-based weapons systems. Whereas natural antibodies have structures that are determined by the ...

Type 1 diabetes is an autoimmune disease characterized by progressive loss of pancreatic beta cells. Golimumab is a human monoclonal antibody specific for tumor necrosis factor α that has already been ...

The effect of enoxaparin on inflammatory and thrombotic mediators in cancer patients as studied using protein and biochip array approaches. This is an ASCO Meeting Abstract from the 2011 ASCO Annual ...